查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448825

全球腫瘤學人工智慧市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global AI In Oncology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 293 Pages | 商品交期: 最快1-2個工作天內

價格

全球腫瘤市場人工智慧需求預計將從 2023 年的 40.2 億美元達到近 93 億美元的市場規模，2024 年至 2032 年研究期間CAGR為 9.77%。

腫瘤學中的人工智慧涉及在癌症診斷、治療計劃和研究中使用人工智慧 (AI)，例如機器學習演算法。人工智慧工具分析大量醫療資料，包括影像研究、遺傳資訊和臨床記錄，以幫助醫療保健專業人員做出更精確和個人化的決策。這些技術可以增強早期癌症檢測、預測治療結果並推薦客製化療法。腫瘤學人工智慧有望改善患者治療結果、最佳化治療策略並增進我們對癌症生物學的理解。

市場動態

癌症診斷和治療決策日益複雜，推動了腫瘤學市場的人工智慧發展，導致腫瘤學對人工智慧 (AI) 解決方案的依賴日益增加。包括機器學習和影像分析在內的人工智慧應用可幫助醫療保健專業人員解讀醫學影像、識別生物標記和製定個人化治療計劃。大量的腫瘤資料，加上對精準醫療的需求，推動了人工智慧在腫瘤學領域的應用。提高診斷準確性、預測治療反應和最佳化患者治療結果的能力有助於市場成長。此外，科技公司與醫療機構之間的合作以及對基於人工智慧的醫療解決方案的監管支持進一步推動了腫瘤市場的人工智慧。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球腫瘤學人工智慧市場的各個細分市場進行了包容性評估。人工智慧在腫瘤學行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

腫瘤學人工智慧市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

依組件類型

  • 軟體解決方案
  • 硬體
  • 服務

按癌症類型

  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 大腸直腸癌
  • 腦腫瘤
  • 其他

按應用

  • 診斷（病理學、癌症放射學）
  • 放射治療（放射治療）
  • 研究與開發（藥物設計、開發流程等）
  • 化療
  • 免疫療法

依最終用途類型

  • 醫院
  • 外科中心和醫療機構
  • 其他（製藥公司、研究所和培訓中心）

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲腫瘤學人工智慧市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。腫瘤學人工智慧市場的主要參與者包括 Azra AI、IBM、西門子醫療有限公司、英特爾公司、GE HealthCare、Nvidia 公司、Digital Diagnostics Inc.、ConcertAI、Median Technologies、PathAI。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：腫瘤學中的人工智慧 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按組件類型分類的市場吸引力分析
    • 按癌症類型分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途類型分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球腫瘤學人工智慧市場分析：按組成部分類型

  • 按組件類型概述
  • 歷史和預測數據
  • 依組件類型分析
  • 軟體解決方案
  • 硬體
  • 服務

第 6 章：全球腫瘤學人工智慧市場分析：按癌症類型

  • 按癌症類型概述
  • 歷史和預測數據
  • 按癌症類型分析
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 大腸直腸癌
  • 腦腫瘤
  • 其他

第 7 章：全球腫瘤學人工智慧市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 診斷（病理學、癌症放射學）
  • 放射治療（放射治療）
  • 研究與開發（藥物設計、開發流程等）
  • 化療
  • 免疫療法

第 8 章：全球腫瘤學人工智慧市場分析：按最終用途類型

  • 按最終用途類型分類的概述
  • 歷史和預測數據
  • 依最終用途類型分析
  • 醫院
  • 外科中心和醫療機構
  • 其他（製藥公司、研究所和培訓中心）

第 9 章：全球腫瘤學人工智慧市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：腫瘤公司人工智慧的競爭格局

  • 人工智慧在腫瘤市場競爭的應用
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Azra AI
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • IBM
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Siemens Healthcare GmbH
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Intel Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GE HealthCare
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Nvidia Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Digital Diagnostics Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • ConcertAI
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Median Technologies
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • PathAI
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113824

The global demand for AI In Oncology Market is presumed to reach the market size of nearly USD 9.3 Billion by 2032 from USD 4.02 Billion in 2023 with a CAGR of 9.77% under the study period 2024 - 2032.

AI in Oncology involves using artificial intelligence (AI), such as machine learning algorithms, in cancer diagnosis, treatment planning, and research. AI tools analyze vast amounts of medical data, including imaging studies, genetic information, and clinical records, to assist healthcare professionals in making more precise and personalized decisions. These technologies can enhance early cancer detection, predict treatment outcomes, and recommend tailored therapies. Artificial Intelligence for oncology holds promise for improving patient outcomes, optimizing treatment strategies, and advancing our understanding of cancer biology.

MARKET DYNAMICS

The AI in oncology market is propelled by the increasing complexity of cancer diagnosis and treatment decisions, leading to a growing reliance on artificial intelligence (AI) solutions in oncology. AI applications, including machine learning and image analysis, assist healthcare professionals in interpreting medical images, identifying biomarkers, and personalized treatment plans. The vast amount of oncological data, coupled with the need for precision medicine, drives the adoption of AI in oncology. The ability to enhance diagnostic accuracy, predict treatment responses, and optimize patient outcomes contributes to market growth. Additionally, collaborations between technology companies and healthcare institutions and regulatory support for AI-based medical solutions further boost AI in oncology market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ai in oncology. The growth and trends of ai in oncology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ai in oncology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component Type

  • Software Solutions
  • Hardware
  • Services

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others

By Application

  • Diagnostics (Pathology, Cancer Radiology)
  • Radiation Therapy (Radiotherapy)
  • Research & Development (Drug Design, Development Process, Etc.)
  • Chemotherapy
  • Immunotherapy

By End-Use Type

  • Hospitals
  • Surgical Centers & Medical Institutes
  • Others (Pharmaceutical Companies, Research Institutes & Training Centers)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the AI In Oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the AI In Oncology market include Azra AI, IBM, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, Nvidia Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . AI IN ONCOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Component Type
    • 3.7.2 Market Attractiveness Analysis By Cancer Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use Type
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY COMPONENT TYPE

  • 5.1 Overview by Component Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Component Type
  • 5.4 Software Solutions Historic and Forecast Sales by Regions
  • 5.5 Hardware Historic and Forecast Sales by Regions
  • 5.6 Services Historic and Forecast Sales by Regions

6 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY CANCER TYPE

  • 6.1 Overview by Cancer Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Cancer Type
  • 6.4 Breast Cancer Historic and Forecast Sales by Regions
  • 6.5 Lung Cancer Historic and Forecast Sales by Regions
  • 6.6 Prostate Cancer Historic and Forecast Sales by Regions
  • 6.7 Colorectal Cancer Historic and Forecast Sales by Regions
  • 6.8 Brain Tumor Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Diagnostics (Pathology, Cancer Radiology) Historic and Forecast Sales by Regions
  • 7.5 Radiation Therapy (Radiotherapy) Historic and Forecast Sales by Regions
  • 7.6 Research & Development (Drug Design, Development Process, etc.) Historic and Forecast Sales by Regions
  • 7.7 Chemotherapy Historic and Forecast Sales by Regions
  • 7.8 Immunotherapy Historic and Forecast Sales by Regions

8 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY END-USE TYPE

  • 8.1 Overview by End-use Type
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-use Type
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Surgical Centers & Medical Institutes Historic and Forecast Sales by Regions
  • 8.6 Others (Pharmaceutical Companies, Research Institutes & Training Centers) Historic and Forecast Sales by Regions

9 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE AI IN ONCOLOGY COMPANIES

  • 10.1. Ai In Oncology Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF AI IN ONCOLOGY INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Azra AI
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. IBM
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Siemens Healthcare GmbH
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Intel Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. GE HealthCare
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Nvidia Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Digital Diagnostics Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. ConcertAI
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Median Technologies
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. PathAI
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Component Type (USD MN)
  • Software Solutions Market Sales by Geography (USD MN)
  • Hardware Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Cancer Type (USD MN)
  • Breast Cancer Market Sales by Geography (USD MN)
  • Lung Cancer Market Sales by Geography (USD MN)
  • Prostate Cancer Market Sales by Geography (USD MN)
  • Colorectal Cancer Market Sales by Geography (USD MN)
  • Brain Tumor Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Diagnostics (Pathology, Cancer Radiology) Market Sales by Geography (USD MN)
  • Radiation Therapy (Radiotherapy) Market Sales by Geography (USD MN)
  • Research & Development (Drug Design, Development Process, etc.) Market Sales by Geography (USD MN)
  • Chemotherapy Market Sales by Geography (USD MN)
  • Immunotherapy Market Sales by Geography (USD MN)
  • Analysis by End-use Type (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Surgical Centers & Medical Institutes Market Sales by Geography (USD MN)
  • Others (Pharmaceutical Companies, Research Institutes & Training Centers) Market Sales by Geography (USD MN)
  • Global Ai In Oncology Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Ai In Oncology Report
  • Market Research Process
  • Market Research Methodology
  • Global Ai In Oncology Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Component Type
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Component Type (USD MN)
  • Software Solutions Market Sales by Geography (USD MN)
  • Hardware Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Cancer Type (USD MN)
  • Breast Cancer Market Sales by Geography (USD MN)
  • Lung Cancer Market Sales by Geography (USD MN)
  • Prostate Cancer Market Sales by Geography (USD MN)
  • Colorectal Cancer Market Sales by Geography (USD MN)
  • Brain Tumor Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Diagnostics (Pathology, Cancer Radiology) Market Sales by Geography (USD MN)
  • Radiation Therapy (Radiotherapy) Market Sales by Geography (USD MN)
  • Research & Development (Drug Design, Development Process, etc.) Market Sales by Geography (USD MN)
  • Chemotherapy Market Sales by Geography (USD MN)
  • Immunotherapy Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use Type (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Surgical Centers & Medical Institutes Market Sales by Geography (USD MN)
  • Others (Pharmaceutical Companies, Research Institutes & Training Centers) Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.